Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fluoropyrimidine Tailored-dose Based on Uracil Concentration in Patients Treated for Digestive Carcinomas: Evaluation of Clinical Practice

NCT04918264 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT04918264
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04918264 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fluoropyrimidine Tailored-dose Based on Uracil Concentration in Patients Treated for Digestive Carcinomas: Evaluation of Clinical Practice
Lead sponsor
Hospices Civils de Lyon
Phase
Observational
Overall status
Completed
Start date
November 2, 2020
Completion date
April 15, 2021
Enrollment
334 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

digestive carcinoma